Nesiritide for the treatment of pulmonary hypertension and cor pulmonale in an infant

Pediatric Cardiology

Volumn 28, Issue 3, 2007, Pages 229-233

  Reynolds, E W ^a   Conely, E T ^a   Vranicar, M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

B type natriuretic peptide; Cor pulmonale; Nesiritide; Pulmonary hypertension

Indexed keywords

BRONCHODILATING AGENT; DIURETIC AGENT; NESIRITIDE; NITRIC OXIDE; SILDENAFIL; STEROID;

ARTICLE; CASE REPORT; CONTINUOUS INFUSION; COR PULMONALE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG SAFETY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PULMONARY HYPERTENSION; SIDE EFFECT; TREATMENT OUTCOME; VOMITING;

ADULT; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PULMONARY HEART DISEASE;

EID: 34248643721     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-0064-6     Document Type: Article

References (20)

1. Cargill RI, Lipworth BJ (1996) Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Chest 110:1220-1225
2. Feingold B, Law YM (2004) Nesiritide use in pediatric patients with congestive heart failure. J Heart Lung Transplant 23:1455-1459
3. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS (2005) The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147:38-42
4. Itoh H, Pratt RE, Dzau VJ (1990) Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86:1690-1697
5. Kunii Y, Kamada M, Ohtsuki S, et al. (2003) Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57:191-197
6. Mahle WT, Cuadrado AR, Kirshbom PM, Kanter KR, Simsic JM (2005) Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med 6:543-546
7. Marshall J, Berkenbosch JW, Russo P, Tobias JD (2004) Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 19:164-170
8. Mathews B, Russel JA, Steinhorn RH, et al. (2006) B-type natriuretic peptide (BNP) system in an ovine model of persistent pulmonary hypertension of the newborn (PPHN). PAS 59:3875.6 [Abstract]
9. Moffett BS, Chang AC (2006) Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol 27:533-551
10. Moffett BS, Jefferies JL, Rossano J, Towbin JA (2006) Nesiritide therapy in a term neonate with renal disease. Pharmacotherapy 26:281-284
11. Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension. Pediatrics 114:1297-1304
12. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K (2005) Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. J Am Med Assoc 293:1900-1905
13. Sackner-Bernstein JD, Skopicki HA, Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491
14. Sanjeev S, Pettersen M, Lua J, et al. (2005) Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25:709-713
15. Schamberger MS (2004) Is there a use for nesiritide in pediatric patients? J Intensive Care Med 19:171-173
16. Sehra R, Underwood K (2006) Nesiritide use for critically ill children awaiting cardiac transplant. Pediatr Cardiol 27:47-50
17. Tammela OK, Koivisto ME (1992) A 1-year follow-up of low birth weight infants with and without bronchopulmonary dysplasia: health, growth, clinical lung disease, cardiovascular and neurological sequelae. Early Human Dev 30:109-120
18. Thierry S, Lecuyer L, Brocas E, et al. (2006) Interest of the brain natriuretic peptide as a marker of acute cor pulmonale in acute respiratory distress syndrome. Ann Fr Anesth Reanim 25:815-819
19. Yap LB (2004) B-type natriuretic peptide and the right heart. Heart Failure Rev 9:99-105
20. Yap LB, Mukerjee D, Timmms PM, Ashrafian H, Coghlan JG (2004) Natriuretic peptides, respiratory disease, and the right heart. Chest 126:1330-1336